Masimo Corp. (NASDAQ:MASI) CEO Joe E. Kiani sold 400 shares of the firm’s stock in a transaction dated Tuesday, September 20th. The shares were sold at an average price of $60.16, for a total transaction of $24,064.00. Following the sale, the chief executive officer now directly owns 120,240 shares in the company, valued at approximately $7,233,638.40. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
Masimo Corp. (NASDAQ:MASI) opened at 60.32 on Friday. Masimo Corp. has a 12-month low of $33.03 and a 12-month high of $60.52. The stock has a market cap of $2.98 billion, a P/E ratio of 31.63 and a beta of 0.80. The company has a 50 day moving average of $58.52 and a 200-day moving average of $49.84.
Masimo Corp. (NASDAQ:MASI) last released its quarterly earnings data on Wednesday, August 3rd. The company reported $0.57 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.41 by $0.16. Masimo Corp. had a net margin of 15.40% and a return on equity of 29.07%. The company earned $172.64 million during the quarter, compared to analyst estimates of $166.02 million. During the same period in the prior year, the firm earned $0.36 earnings per share. The firm’s revenue for the quarter was up 10.9% compared to the same quarter last year. Equities analysts forecast that Masimo Corp. will post $2.02 earnings per share for the current year.
A number of analysts have recently issued reports on the stock. BTIG Research reaffirmed a “hold” rating on shares of Masimo Corp. in a report on Friday, August 5th. Piper Jaffray Cos. reaffirmed an “overweight” rating and set a $55.00 price target (up previously from $52.00) on shares of Masimo Corp. in a report on Friday, August 5th. Raymond James Financial Inc. downgraded shares of Masimo Corp. from a “strong-buy” rating to an “outperform” rating in a report on Wednesday, June 1st. Finally, Wedbush reaffirmed an “outperform” rating and set a $63.00 price target (up previously from $60.00) on shares of Masimo Corp. in a report on Thursday, August 4th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company. The stock has an average rating of “Buy” and an average target price of $52.60.
A number of hedge funds have recently added to or reduced their stakes in MASI. UBS Group AG raised its stake in Masimo Corp. by 3.6% in the first quarter. UBS Group AG now owns 19,177 shares of the company’s stock worth $802,000 after buying an additional 663 shares during the period. State Street Corp increased its position in shares of Masimo Corp. by 3.1% in the first quarter. State Street Corp now owns 890,937 shares of the company’s stock worth $37,271,000 after buying an additional 26,485 shares in the last quarter. Zebra Capital Management LLC increased its position in shares of Masimo Corp. by 20.9% in the first quarter. Zebra Capital Management LLC now owns 21,916 shares of the company’s stock worth $917,000 after buying an additional 3,783 shares in the last quarter. Spark Investment Management LLC purchased a new position in shares of Masimo Corp. during the first quarter worth approximately $2,092,000. Finally, Huntington Asset Advisors Inc. purchased a new position in shares of Masimo Corp. during the first quarter worth approximately $513,000. 79.88% of the stock is owned by institutional investors.
About Masimo Corp.
Masimo Corporation is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The Company’s business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include monitoring blood constituents with an optical signature, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring.
Receive News & Ratings for Masimo Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corp. and related companies with MarketBeat.com's FREE daily email newsletter.